The medical, surgical and catheter-based treatment of peripheral arterial disease (PAD) is a combined effort of the Emory Heart & Vascular Center, the Division of Vascular Surgery & Endovascular Therapy as well as the section of Interventional Radiology. Emory’s physicians are national leaders in the diagnosis, treatment and research of peripheral arterial disease (PAD), also known as peripheral vascular disease (PVD). The challenge with this life-threatening disease is at least half of the people who have PAD don't have any signs or symptoms. And, unfortunately, an artery can be blocked by 60 percent before a patient even realizes something may be wrong.
Because atherosclerosis is a systemic (affects the entire body) disease, it is common for people with PAD to have blocked arteries in other areas of the body. The eight to 12 million people in the U.S. who suffer from PAD are at increased risk for heart disease, aortic aneurysms and stroke. PAD is also a marker for diabetes, hypertension and other conditions.
It is estimated that less than two million people are actually diagnosed with PAD and less than 700,000 are treated each year.